Research-use agreement required

You must actively agree before entering Revalin.

Research-grade chemicals for in-vitro and pre-clinical use
Independently tested by Janoshik Analytical
Published COAs with every batch

All products are strictly for research purposes only and are not intended for human consumption. These products have not been evaluated or approved by the FDA or Health Canada.

You must be 21 or older to browse this site.

Optional research details

Leaving these fields blank records that no institution or research details were provided.

This is the research-use access gate, separate from cookie consent.

By clicking Yes, you confirm you are 21 or older, are acting for lawful research purposes, and agree to our Terms of Service and Privacy Policy.

Independently Verified>99% PuritySame-Day DispatchFree Shipping $250 USD / $350 CAD+Research Use OnlyUser Discretion AdvisedIndependently Verified>99% PuritySame-Day DispatchFree Shipping $250 USD / $350 CAD+Research Use OnlyUser Discretion Advised
  • Home
  • Shop
  • Research
  • COA
  • Log in

Research library

Peer-reviewed papers, curated.

Every paper cross-linked to the compound it studies.

Filter by compound or topic.

No marketing copy — the literature, as published.

Back to research hub

Compound

AllGHK-CUGLP-1/GIP/Glucagon Triple Agonist

Topic

AllGIPGLP-1GlucagonMetabolic ResearchTriple AgonistWomen's Health
Clear filters
  • Instagram

Research library

Papers & protocols, as published.

Curated research chemical literature from the Revalin team. All content is intended for licensed researchers working in laboratory settings.

Compound

AllGHK-CUGLP-1/GIP/Glucagon Triple Agonist

Topic

AllGIPGLP-1GlucagonMetabolic ResearchTriple AgonistWomen's Health
Clear filters
Retatrutide and Women's Health: The Definitive 2026 Research Review

Women's Health

Retatrutide and Women's Health: The Definitive 2026 Research Review

The GLP-3 triple agonist is rewriting the rules of obesity medicine — and for women, the implications go far beyond the scale. This research review covers Phase 3 trial data showing 28.7% average weight loss, groundbreaking cancer findings in triple-negative breast cancer and pancreatic tumors, hormonal restoration in PCOS, 90% liver fat normalization in MASH, and cardiovascular breakthroughs — all sourced from NEJM, The Lancet, Nature Medicine, and the full TRIUMPH clinical program.

31 min readRead paper

Shop

  • Metabolic
  • Somatotropic
  • Regenerative
  • Endocrine
  • Melanocortin
  • Reconstitution
  • Neuroactive

support@revalin.ca

Revalin products are for research purposes only. Not for human consumption or clinical use. The buyer is responsible for adhering to all local laws and regulations. Revalin is not a pharmacy and does not provide medical advice, prescriptions, or consultations.

Research-grade chemicals. >99% purity. Third-party tested.

Revalin products are for research purposes only. Not for human consumption or clinical use. The buyer is responsible for adhering to all local laws and regulations. Revalin is not a pharmacy and does not provide medical advice, prescriptions, or consultations.

ResearchCOAAboutFAQShipping & ReturnsContactGrowTerms of ServicePrivacy Policy
ResearchCOAAboutFAQShipping & ReturnsContactGrowTerms of ServicePrivacy Policy

2026© — All rights reserved